First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study
晚期肝细胞癌一线治疗：阿特珠单抗/贝伐珠单抗或度伐利尤单抗/曲美木单抗：一项真实世界多中心回顾性研究
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf286
Kournoutas, Ioannis; Marell, Paulina; Gile, Jennifer; Peersen, Anina; Shah, Priyanshi; VanDommelen, Kyle; Kamath, Suneel D; Gupta, Garima; Akce, Mehmet; Yang, Ju Dong; Chen, Pin-Jung; Naleid, Nikolas; Mahipal, Amit; Peterson, Nicole; Sahai, Vaibhav; Wee Ma, Wen; Jin, Zhaohui; Halfdanarson, Thorvardur; Fonkoua Kankeu, Lionel; Washburn, Leslie A; Conboy, Caitlin B; Torbenson, Michael; Goenka, Ajit; Thompson, Scott; Venkatesh, Sudhakar K; Starlinger, Patrick; Roberts, Lewis; Gores, Gregory J; Babiker, Hani; Ahn, Daniel; Borad, Mitesh; Bekaii-Saab, Tanios; Jatoi, Aminah; McWilliams, Robert R; Ou, Fang-Shu; Tran, Nguyen H
